Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
SEC Regulatory Changes Provide Small Biotech Companies Relief from Burdensome Requirements
March 12, 2020
The Securities and Exchange Commission (SEC) has adopted regulatory changes to provide small public companies with a temporary exemption from Sarbanes-Oxley 404(b) compliance. 404(b) requires public companies to report on the internal controls they…
BIO Statement Urging USDA Adoption of Pre-Market Notification Process within Biotech Reg System
March 6, 2020
Washington, D.C. (March 6, 2020) – The following statement can be attributed to Dana O’Brien, BIO’s Executive Vice President for Food & Agriculture urging USDA to establish a pre-market notification process within its plant biotechnology…
BIO Asia Conference in Tokyo Cancelled Amid COVID-19 Outbreak
February 21, 2020
Washington, DC – February 21, 2020 - The Biotechnology Innovation Organization (BIO) announced today, it is canceling the annual BIO Asia conference in Tokyo scheduled for March 10-11. The decision was based on the global impact of COVID-19 and…
A Patient Advocate’s Perspective on Foreign Price Controls
February 7, 2020
In a new video, Cynthia Bens, patient advocate and Senior Vice President of Public Policy at the Personalized Medicine Coalition, shares her views on how adopting foreign price controls for prescription medicines will impact patients in the U.S. …
Patients, Scientists and Researchers Will Be Watching the State of the Union
February 4, 2020
Ahead of tonight’s State of the Union Address, Jim Greenwood, President and CEO of the Biotechnology Innovation Organization, shared what he hopes President Trump will say to America’s patients counting on the development of new medicines and cures,…
Adopting foreign price controls “prevents investors from being able to invest, and inventors from being able to invent.”
February 3, 2020
In a new video, Alex Karnal, a life science investor and partner at Deerfield Management, shares why investing in new cures and treatments is personal, and he explains how President Trump’s plan to import foreign price controls would have an …
Biotech Leader Rachel King Urges President Trump to Reject Foreign Price Controls, Ensure U.S. Continues to Lead in Innovation
January 31, 2020
Rachel King is co-founder and CEO of GlycoMimetics, a biotech company based in Rockville, Maryland that is working hard to develop new treatments for patients with various diseases of the blood. In a new video, Mrs. King explains why President Trump…
Survey shows only 15% of executives and 14% of biotech board members are people of color.
January 29, 2020
WASHINGTON DC., January 30, 2020 – The Biotechnology Innovation Organization (BIO) today released “Measuring Diversity in the Biotech Industry: Building an Inclusive Workforce,” the most comprehensive report on diversity and inclusion in the…
China Phase I Agreement Represents Important Step Towards Addressing Biotech Issues
January 15, 2020
Washington, D.C. (January 15, 2020) – BIO President and CEO Jim Greenwood released the following statement today regarding the signing of Phase One of the trade agreement with China: “Trade issues with China have long been a priority for BIO and…
Washington State’s Clean Fuels Program Takes to the Skies with Alaska Airlines
January 10, 2020
Today, the Sustainable Aviation Fuels (SAF) Producers Group together with the Biotechnology Innovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) issued the following statement commending Alaska Airlines’ support for including…